文献速递生殖医学

人冻存卵巢组织移植至腹膜下腹部部位的经验

Experience with transplantation of human cryopreserved ovarian tissue to a sub-peritoneal abdominal site.
PubMed 文献 · Hum Reprod · 2021-01-01

本研究评估了将冻存卵巢组织移植至腹膜下腹部部位的可行性,并与卵巢及盆腔腹膜部位移植进行比较。17例生育力保存女性的队列数据显示,腹部移植部位可获取成熟卵母细胞并实现活产,其卵母细胞回收率及胚胎发育情况与卵巢和盆腔部位相似。

要点

  • 腹膜下腹部部位可作为冻存卵巢组织移植的可行部位。
  • 腹部部位获取的成熟卵母细胞比例及胚胎发育与卵巢、盆腔部位相似。
  • 对于盆腔部位移植禁忌的患者,腹部移植提供了一种选择。

核心结论

  • 腹膜下腹部部位移植冻存卵巢组织可获得活产,且成熟卵母细胞回收及胚胎发育结局与卵巢和盆腔部位移植相似。

研究设计与样本

  • 队列研究,纳入17例生育力保存女性,冻存卵巢组织慢速冷冻后移植至腹膜下腹部、盆腔侧壁腹膜袋及卵巢,追踪各部位卵泡抽吸结局。

主要发现

  • 卵巢组织获取至移植平均间隔6年,首次移植后平均4.2个月恢复月经周期,各移植部位无差异。
  • 抽吸日平均卵泡直径所有部位均为14 mm。
  • 腹部卵泡抽吸未获卵母细胞的比例为30%(36/120),卵巢为24%(21/87),盆腔为32%(31/97)。
  • 回收卵母细胞成熟比例:腹部67%(50/75),卵巢68%(42/62),盆腔59%(34/58)。
  • 受精后第2天胚胎发育比例:腹部90%(34/38),卵巢76%(22/29),盆腔96%(22/23)。

临床怎么用

  • 对于盆腔部位移植禁忌的女性,可考虑将冻存卵巢组织移植至腹膜下腹部部位。
  • 腹部卵泡抽吸可在超声引导下经腹部进行,卵巢和盆腔卵泡经阴道抽吸。
  • 触发卵泡成熟时卵泡直径可能需低于常规阈值。

局限性

  • 研究样本量小。
  • 卵泡密度仅为估计值,且移植组织量在患者间存在差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Is a sub-peritoneal abdominal site a suitable site for cryopreserved ovarian tissue transplantation? SUMMARY ANSWER: Live births have resulted from oocytes aspirated from follicles within cryopreserved ovarian tissue transplanted in a sub-peritoneal abdominal site with similar outcomes observed in terms of number of mature oocytes recovered and embryo development from tissue transplanted to sub-peritoneal abdominal, ovarian, and pelvic sites in our clinic. WHAT IS KNOWN ALREADY: Over 130 live births have been reported from cryopreservation of ovarian tissue and subsequent transplantation. In the majority of these, tissue was transplanted onto the remaining ovary. Although grafting to a non-ovarian, non-pelvic, sub-peritoneal abdominal site has resulted in births, it has been suggested that compromised outcomes may be expected from a non-pelvic site. STUDY DESIGN, SIZE, DURATION: The aim of the study was to assess the outcome from cryopreserved ovarian tissue transplanted to a site out of the pelvic area; a sub-peritoneal abdominal site. These outcomes were compared to transplantation to the ovary and peritoneal pelvic area in a cohort of 17 fertility preservation women where the individual sites of follicle aspiration were known and subsequent outcomes tracked. Ovarian tissue was slow frozen using the cryoprotectants propanediol and sucrose (n = 16 women) or using dimethyl sulfoxide and sucrose (n = 1 woman). Tissue was kept at 4°C overnight prior to freezing for 1 case. Tissue was thawed appropriately and prepared on 6.0 vicryl sutures for transplantation. Tissue was placed laparoscopically into a sub-peritoneal abdominal site, a pelvic side wall peritoneal pocket and the ovary. PARTICIPANTS/MATERIALS, SETTING, METHODS: Following resumption of cycling, gonadotrophin stimulation commenced with FSH, LH and antagonist and a trigger was given when one follicle was >13 mm in diameter. Abdominal follicles were aspirated under ultrasound guidance trans-abdominally; ovarian and pelvic follicles were aspirated trans-vaginally. Due to an inability to differentiate pelvic from ovarian follicles at the time of ultrasound-guided oocyte retrieval, both were classified as ovarian on the side where both were present. However, on the side, where no ovary was present, outcomes from pelvic follicles were reported. MAIN RESULTS AND THE ROLE OF CHANCE: Average time lapse between ovarian tissue harvest and graft was 6 years. Resumption of cycling occurred on average 4.2 months post first graft, regardless of graft site. Mean follicle diameter on the day of oocyte aspiration was 14 mm for all sites. Aspiration failed to retrieve an oocyte in 30% (36/120) of abdominal follicles which was similar to the other sites; ovarian 24% (21/87), pelvic 32% (31/97). A similar proportion of retrieved oocytes was mature from all sites (67% (50/75) abdominal, 68% (42/62) ovarian, 59% (34/58) pelvic). The proportion of embryos which developed on Day 2 from those fertilized was also similar in all groups (90% (34/38) abdominal, 76% (22/29) ovarian, 96% (22/23) pelvic). To our knowledge, this is the first report of outcomes from cryopreserved ovarian tissue transplanted to a sub-peritoneal abdominal site and the subsequent comparison to outcomes from the ovary and a sub-peritoneal pelvic graft, within the same cohort of patients, where tissue was slow frozen predominantly with the cryoprotectant propanediol and sucrose. LIMITATIONS, REASONS FOR CAUTION: The study reports outcomes from a small number of women following ovarian tissue transplantation. Follicle density is an estimate only and the amount of tissue grafted varied between patients. WIDER IMPLICATIONS OF THE FINDINGS: The demonstration of successful outcomes from cryopreserved ovarian tissue grafted to a sub-peritoneal abdominal site has significant implications for the management of women in which grafting to pelvic sites is contraindicated although it appears to be important to trigger follicle maturation at a lower than normal follicular diameter. The relative ease of oocyte retrieval at the sub-peritoneal abdominal site also has positive implications for the introduction of this approach into clinical practice. STUDY FUNDING/COMPETING INTEREST(S): No specific funding was used. All authors have no conflict of interest. TRIAL REGISTRATION NUMBER: N/A.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Gook D, Hale L, Polyakov A, et al. Experience with transplantation of human cryopreserved ovarian tissue to a sub-peritoneal abdominal site. Hum Reprod. 2021. PMID: 34255039. doi:10.1093/humrep/deab167

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。